Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the works, but any such program ...

Q2 2025 Earnings Call Transcript August 1, 2025 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

Regeneron Pharmaceuticals delivered strong Q2 results and made net progress with its commercial portfolio and pipeline. Click ...

Weight loss drugs could be a gamechanger for women with a common hormonal disorder By Annika Kim Constantino, CNBC • Published July 20, 2025 • Updated on July 21, 2025 at 1:33 pm ...